Metraipolis › archive › dc_71ec314db882

Cardiorenal Safety Markers With Injectable Glucagon-Like Peptide-1 (GLP-1) Agonists in Type 2 Diabetes: A Network Meta-Analysis — Europe PMC PMID:41367446

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41367446
DOI
10.7759/cureus.96162
License (as archived)
solo-consultazione
Archived
2026-11-08T18:37:30.958Z
SHA-256 of the archived text
c5f3ceea0cf9e58bc29546cd3d9411e925b6134cb396102683c6f8ebb723053c
Stable URL of this page
https://metraipolis.com/documento/dc_71ec314db882

How to cite

Cardiorenal Safety Markers With Injectable Glucagon-Like Peptide-1 (GLP-1) Agonists in Type 2 Diabetes: A Network Meta-Analysis — Europe PMC PMID:41367446 — Europe PMC (en), https://europepmc.org/article/MED/41367446 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_71ec314db882 (Metraipolis archive dc_71ec314db882, sha256 c5f3ceea0cf9e58bc29546cd3d9411e925b6134cb396102683c6f8ebb723053c)
BibTeX
@misc{dc71ec314db882,
  title = {Cardiorenal Safety Markers With Injectable Glucagon-Like Peptide-1 (GLP-1) Agonists in Type 2 Diabetes: A Network Meta-Analysis — Europe PMC PMID:41367446},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41367446},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_71ec314db882; sha256 c5f3ceea0cf9e58bc29546cd3d9411e925b6134cb396102683c6f8ebb723053c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41367446. Agents can read the archived copy with the MCP tool read_document.